v3.24.3
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock (Class A and B)
Additional Paid-in-Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning of the period (in shares) at Dec. 31, 2022   52,652,000      
Beginning of the period at Dec. 31, 2022 $ 5,983 $ 53 $ 537,732 $ (6,686) $ (525,116)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 38,042   38,042    
Issuance of common stock upon exercise of stock options (in shares)   102,000      
Issuance of common stock upon exercise of stock options 1,457   1,457    
Issuance of common stock under employee stock purchase plan (in shares)   107,000      
Issuance of common stock under employee stock purchase plan 5,546   5,546    
Issuance of restricted stock units (in shares)   449,000      
Tax withholding related to net share settlements of stock-based compensation awards (in shares)   (78,000)      
Tax withholding related to net share settlements of stock-based compensation awards (7,228)   (7,228)    
Net loss (46,150)       (46,150)
Other comprehensive income (loss) 3,280     3,280  
End of period (in shares) at Mar. 31, 2023   53,232,000      
End of period at Mar. 31, 2023 930 $ 53 575,549 (3,406) (571,266)
Beginning of the period (in shares) at Dec. 31, 2022   52,652,000      
Beginning of the period at Dec. 31, 2022 5,983 $ 53 537,732 (6,686) (525,116)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (123,329)        
Other comprehensive income (loss) 291        
End of period (in shares) at Sep. 30, 2023   54,019,000      
End of period at Sep. 30, 2023 (113,693) $ 54 541,093 (6,395) (648,445)
Beginning of the period (in shares) at Mar. 31, 2023   53,232,000      
Beginning of the period at Mar. 31, 2023 930 $ 53 575,549 (3,406) (571,266)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 20,610   20,610    
Issuance of common stock upon exercise of stock options (in shares)   47,000      
Issuance of common stock upon exercise of stock options 747 $ 1 746    
Issuance of restricted stock units (in shares)   266,000      
Tax withholding related to net share settlements of stock-based compensation awards (in shares)   (12,000)      
Tax withholding related to net share settlements of stock-based compensation awards (1,212)   (1,212)    
Net loss (20,910)       (20,910)
Other comprehensive income (loss) (8)     (8)  
End of period (in shares) at Jun. 30, 2023   53,533,000      
End of period at Jun. 30, 2023 157 $ 54 595,693 (3,414) (592,176)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 19,377   19,377    
Issuance of common stock upon exercise of stock options (in shares)   70,000      
Issuance of common stock upon exercise of stock options 1,120   1,120    
Issuance of common stock under employee stock purchase plan (in shares)   93,000      
Issuance of common stock under employee stock purchase plan 6,967   6,967    
Issuance of restricted stock units (in shares)   332,000      
Tax withholding related to net share settlements of stock-based compensation awards (in shares)   (9,000)      
Tax withholding related to net share settlements of stock-based compensation awards (984)   (984)    
Induced conversion of convertible senior notes (81,080)   (81,080)    
Net loss (56,269)       (56,269)
Other comprehensive income (loss) (2,981)     (2,981)  
End of period (in shares) at Sep. 30, 2023   54,019,000      
End of period at Sep. 30, 2023 (113,693) $ 54 541,093 (6,395) (648,445)
Beginning of the period (in shares) at Dec. 31, 2023   54,179,000      
Beginning of the period at Dec. 31, 2023 (89,390) $ 54 562,942 255 (652,641)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 23,007   23,007    
Issuance of common stock upon exercise of stock options (in shares)   19,000      
Issuance of common stock upon exercise of stock options 302 $ 1 301    
Issuance of common stock under employee stock purchase plan (in shares)   88,000      
Issuance of common stock under employee stock purchase plan 7,113   7,113    
Issuance of restricted stock units (in shares)   590,000      
Tax withholding related to net share settlements of stock-based compensation awards (in shares)   (91,000)      
Tax withholding related to net share settlements of stock-based compensation awards (8,611)   (8,611)    
Net loss (11,687)       (11,687)
Other comprehensive income (loss) (3,890)     (3,890)  
End of period (in shares) at Mar. 31, 2024   54,785,000      
End of period at Mar. 31, 2024 (83,156) $ 55 584,752 (3,635) (664,328)
Beginning of the period (in shares) at Dec. 31, 2023   54,179,000      
Beginning of the period at Dec. 31, 2023 $ (89,390) $ 54 562,942 255 (652,641)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 245,202        
Net loss $ (46,227)        
Other comprehensive income (loss) 2,664        
End of period (in shares) at Sep. 30, 2024   55,373,000      
End of period at Sep. 30, 2024 (50,810) $ 56 645,083 2,919 (698,868)
Beginning of the period (in shares) at Mar. 31, 2024   54,785,000      
Beginning of the period at Mar. 31, 2024 (83,156) $ 55 584,752 (3,635) (664,328)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 25,402   25,402    
Issuance of common stock upon exercise of stock options (in shares)   18,000      
Issuance of common stock upon exercise of stock options 290   290    
Issuance of restricted stock units (in shares)   131,000      
Tax withholding related to net share settlements of stock-based compensation awards (in shares)   (20,000)      
Tax withholding related to net share settlements of stock-based compensation awards (1,640)   (1,640)    
Net loss (17,548)       (17,548)
Other comprehensive income (loss) (1,095)     (1,095)  
End of period (in shares) at Jun. 30, 2024   54,914,000      
End of period at Jun. 30, 2024 (77,747) $ 55 608,804 (4,730) (681,876)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 27,470   27,470    
Issuance of common stock upon exercise of stock options (in shares)   208,000      
Issuance of common stock upon exercise of stock options 3,274 $ 1 3,273    
Issuance of common stock under employee stock purchase plan (in shares)   106,000      
Issuance of common stock under employee stock purchase plan 6,709   6,709    
Issuance of restricted stock units (in shares)   160,000      
Tax withholding related to net share settlements of stock-based compensation awards (in shares)   (15,000)      
Tax withholding related to net share settlements of stock-based compensation awards (1,173)   (1,173)    
Net loss (16,992)       (16,992)
Other comprehensive income (loss) 7,649     7,649  
End of period (in shares) at Sep. 30, 2024   55,373,000      
End of period at Sep. 30, 2024 $ (50,810) $ 56 $ 645,083 $ 2,919 $ (698,868)